About the firm
Legacy DNA is a growth partner for mid-market healthtech and pharmacy companies operating under real enterprise-value and exit pressure.
We work with founders, executive teams, and private equity operators who already have strong businesses. And they need those businesses to be understood, trusted, and valued by buyers.
Our work lives at the intersection of growth, credibility, and transferability. We focus on what buyers care about, how value is created, and whether it will hold up under scrutiny.
Legacy DNA refers to the underlying commercial structure that explains why a business works and whether that value can travel beyond the founder, the current team, or a single growth phase.
We go inside the business to surface that structure, organize it, and make it visible. The result is a commercial story that’s defensible, scalable, and transferable. One buyers can understand, believe, and stand behind.
To us, legacy is both financial and human. It’s enterprise value that rewards the teams who built it, sustains innovation, and creates impact beyond a single transaction.
We operate as a senior, coordinated team built to
deliver results under pressure.
Our team brings together commercialization strategy,
growth leadership, narrative development, creative execution, AI acceleration, and operational rigor. Every role exists to strengthen decision-making, increase execution speed,
and build credibility where it matters most.
Our team members bring experience from:
We’re accustomed to operating alongside executive teams on high-stakes initiatives. The result is a firm that can think strategically, move with speed, and deliver work that holds up in boardrooms, buyer conversations, and diligence reviews.
We help mid-market and PE-backed healthtech and pharmacy leaders transform complexity into clarity, align commercialization with execution, and create enterprise value that lasts beyond a single growth phase or exit.
A healthcare ecosystem where innovations capable of improving lives reach scale because the companies behind them are built, positioned, and valued to endure.
Healthcare doesn’t reward shortcuts.
Pure AI solutions move fast but fail under scrutiny. They lack sector judgment, regulatory awareness, and the credibility needed in complex buying environments.
Legacy DNA uses AI to accelerate insight, pattern recognition, and execution speed. At the same time, our human expertise brings judgment, accountability, and trust.
This balance helps us move quickly while producing quality, scalable work.
We embed AI systems into our workflows to accelerate research, insight generation, and execution, while maintaining senior-level human oversight at every decision point.
AI systems embedded across our work:
All AI systems are designed, governed, and reviewed by senior LDNA leaders. Final strategy, recommendations, and deliverables are always human-owned and client-approved.
Legacy DNA works with leaders who are serious about exit readiness and outcomes.
If our perspective resonates with you, let's have a conversation about whether there’s real alignment and whether it makes sense to work together.